- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00932191
Endothelial Cell Loss After Cataract Surgery
August 21, 2014 updated by: University of California, San Francisco
Endothelial Cell Loss After Cataract Surgery: Comparison of a Reduced Ultrasound Technique Versus Standard Ultrasound Technique
The purpose of this study is to compare two cataract surgical technique variations for removing the nucleus of the lens (central part of the lens) in terms of damage to the inner layer of the cornea which is called the endothelium.
One variation uses more ultrasound energy and the other more mechanical force to break up the nucleus.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Visually significant moderate density cataract
Exclusion Criteria:
- Corneal or retinal pathology limiting visual potential to worse than 20/40
- Lens pathology including pseudoexfoliation or lens dislocation
- Prior intraocular surgery
- Age less than 40
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Ultrasound phacoemulsification
Cataract nucleus is removed using standard amounts of ultrasound energy.
|
Cataract nucleus removal using standard amounts of ultrasound energy
|
|
Active Comparator: Reduced ultrasound phacoemulsification
Cataract nucleus removal using less ultrasound energy and more mechanical energy.
|
Cataract nucleus removal using less ultrasound energy and more mechanical energy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Corneal endothelial cell loss by specular microscopy after cataract surgery
Time Frame: 3 months post-operatively
|
3 months post-operatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: David Hwang, MD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2009
Primary Completion (Actual)
July 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
July 1, 2009
First Submitted That Met QC Criteria
July 2, 2009
First Posted (Estimate)
July 3, 2009
Study Record Updates
Last Update Posted (Estimate)
August 25, 2014
Last Update Submitted That Met QC Criteria
August 21, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DHCrush001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataracts
-
Johnson & Johnson Surgical Vision, Inc.CompletedCataractsUnited States
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
Wenzhou Medical UniversityCompleted
-
Medical University of ViennaCompleted
-
Hermann Eye CenterCompleted
-
Mark Packer, MD, FACSCompletedCataractsUnited States
-
Medical University of ViennaCompleted
Clinical Trials on Standard phacoemulsification
-
University Tunis El ManarCompletedEffect of Cataract Surgery on Corneal Endothelium; About 2 TechniquesTunisia
-
Centre hospitalier de l'Université de Montréal...WithdrawnCataract | Astigmatism | Corneal Endothelial Cell LossCanada
-
State University of New York at BuffaloCompletedGlaucomaUnited States
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...Active, not recruiting
-
University of Turin, ItalyCompleted
-
Sohag UniversityNot yet recruitingPrimary Open Angle Glaucoma
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Cairo UniversityUnknown